A class action, class suit, or representative action is a type of lawsuit where one of the parties is a group of people who are represented collectively by a member of that group.
SOME POPULAR CLASS ACTION LAWSUITS
JOHNSON & JOHNSON
The medical product and device manufacturer decided to recall a medical device that is utilized during hysterectomies and other uterine procedures (such as D & C, Dilation and curettage typically performed post miscarriage or abortion) after it received reports that the device might spread undetected cancer in patients.
The Food and Drug Administration (FDA) warned healthcare providers that the popular device may disperse malignant cancer cells. The FDA found that about 1 in 350 women who go into surgery and have the devices used may have some type of cancer that the medical device can cause to spread past the uterus. Additionally, the spread of these cells into the abdomen and pelvis can substantially decrease a woman’s chance of surviving the cancer.
The Ethicon unit of Johnson & Johnson is the largest manufacturer of these devices. It decided to recall these defective medical devices from the market due to the concerns over the potential to spread cancer. The company decided to pull the product until medical guidelines were created or new technologies were established to decrease this serious health risk.
If you had a hysterectomy and are concerned about your health and potential risks, please contact us today and schedule a free consultation.
TALCUM POWDER/BABY POWDER
*Thousands of women throughout the United States may have developed ovarian cancer from side effects of talcum powder. Lawsuits are being investigated over allegedly inadequate warnings provided by manufacturers who sell talcum-based products under various different names, including Baby Powder, Body Powder and Talc Powder.
Concerns over the potential link between talcum powder and ovarian cancer has been suspected for decades. However, the manufacturers have sold talc body powder as a safe product, withholding important safety information from consumers.
As early as 1971, researchers found talc embedded in 75% of all ovarian tumors researchers studied. In addition, several studies and reports have confirmed that talc applied to a woman’s genital area may travel through the vagina and into the uterus, Fallopian tubes and ovaries.
In June 2013, a study published in the medical journal Cancer Prevention Research found that women who used talcum body powder as a feminine hygiene produce may face a 20% to 30% greater risk of ovarian cancer compared to those who do not apply talc.
As a result of Johnson & Johnson’s and other manufacturers’ failure to disclose the potential ovarian cancer risks women may face, financial compensation may be available through a talcum powder lawsuit or settlement.
The IVC Filter lawsuits state the manufacturers of the IVC blood clot devices failed to warn patients and physicians of the increased risks of the filters breaking, and metal fragments moving through the blood, potentially damaging an organ. Additionally, the lawsuits state that the manufacturer C.R. Bard hid the results of its own research finding the filters dangerous, and even forged an employee’s signature on an FDA application in order to get FDA approval.
Five products are most often involved in an IVC filter lawsuit: The Bard Recovery filter; The Bard G2 filter; The Bard G2 Express filter; The Cook Gunther Tulip filter; and the Cook Celect filter. Other IVC filters causing problems include the Bard Eclipse, Bard Merdian, and Bard Denali.If pieces of the IVC filter break and move to the heart or lungs, symptoms may include:
- Chest Pain
- Heart Rhythm Problems
- Neck Pain
- Shortness of Breath
- Hemorrhaging or Internal Bleeding
In severe cases, injuries can lead to:
- Hemorrhaging (severe bleeding)
- Pulmonary Embolism
If you or a loved one experience any of these symptoms with a Bard IVC Filter, then please contact us today for a free consultation.
Approved in 2011, Xarelto (rivaroxaban) is one of the newest blood thinners on the market and is manufactured by Bayer and marketed in the U.S. by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals.
Xarelto (known generically as Rivaroxaban) is a new-generation anticoagulant, in a class of drugs known as direct thrombin inhibitors. It is a blood thinner used to reduce the risk of blood clots and strokes. Xarelto has also been marketed as being easier to use than warfarin (known by the brand name Coumadin), an older anticoagulant, because it does not require medical monitoring.
Xarelto has reportedly been linked to an increased risk of uncontrollable bleeding (hemorrhaging). A risk of hemorrhaging exists in many blood thinners; however, warfarin has an antidote in that can reduce the risk of uncontrollable hemorrhaging. Some newer blood thinners do not have an antidote. This means that injuries—including minor cuts or internal bleeding—can result in uncontrolled bleeding, which can be fatal.
Injuries alleged to be associated with Xarelto include:
- Retinal hemorrhages
- Epidural hematoma
- Intracranial hemorrhages
- Pulmonary embolism
- Hemoglobin decrease
- Gastrointestinal hemorrhages
- Deep vein thrombosis
- Adrenal bleeding
There are currently more than 4,500 cases consolidated in federal multi-district litigation before Judge Eldon E. Fallon in Louisiana under MDL-2592.
If you or someone you know and love has experienced any of these symptoms and you believe it has been caused by Xarelto, then please contact our office today for a free consultation.